Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
The Clinical Benefits of HDx Therapy for Chronic HD Patients
The Nephrology Dialysis Transplantation (NDT) Journal has published results of two clinical studies comparing with Theranova dialyzer with the latest generation of high-flux dialyzers.Read More
A Focus on Clinical Research
Implementation of an automated peritoneal dialysis program with remote monitoring in a network of renal clinics in Columbia - Mauricio S, et al.
Is Expanded Hemodialysis an Option to Online Hemodiafiltration for Small- and Middle-Sized Molecules Clearance? - Reque J et al.
New medium cut-off membrane vs hemodiafiltration in clearance of middle molecules. Preliminary results from our centre - Albrizio P, et al.
Plasma molecular changes in hemodialysis patients with polyarylethersulfone-polyvinylpyrrolidone membrane dialyzer (Theranova 400 Baxter) - Celik L, et al.
Trends in outcomes for an automated peritoneal dialysis program with and without remote management in Columbia - Sanabria M, et al.
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules - Wolley M, et al.
Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity—a preliminary study - Lorenz et al.
Comparison of Hospitalization Rate in Automatized Peritoneal Dialysis Patients with and Without Remote Management Program in Colombia - Rivera A et al.
Comparison of the removal of uremic toxins with medium cut-off and high-flux dialyzers: a randomized clinical trial - Belmouaz M et al